We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Lung Ultrasound as Good as Chest X-Ray for COVID-19 Diagnosis and Management

By MedImaging International staff writers
Posted on 25 Jan 2022
Illustration
Illustration

A retrospective multicenter study by researchers from Italy, Portugal and Spain has found lung ultrasound (LUS) to be as good as chest X-ray (CXR) for accurate COVID-19 diagnosis.

LUS holds the promise of an accurate, radiation-free, and affordable diagnostic and monitoring tool in coronavirus disease 2019 (COVID-19) pneumonia. The researchers sought to evaluate the usefulness of LUS in the diagnosis of patients with respiratory distress and suspicion of interstitial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, in comparison to other imaging modalities.

In the study, study, LUS was performed on Emergency Department (ED) arrival of patients presenting for possible COVID-19 evaluation, by trained emergency physicians, before undergoing conventional radiologic examination or while waiting for the report. Scans were performed using longitudinal transducer orientation of the lung regions. CXR was interpreted by radiologists staffing ED radiology. The subjects were divided into two groups based on molecular test results. The LUS findings were compared to COVID test results, non-laboratory data, and other imaging for each patient. Categorical variables were expressed as percentages and continuous variables as median ± standard error.

A total of 479 patients were enrolled, out of which 87% were diagnosed with SARS-CoV-2 by molecular testing. COVID positive and COVID negative patients differed with respect to sex, presence of fever, and white blood cells count. The most common findings on lung point of care ultrasound (POCUS) for COVID-positive patients were B-lines, irregular pleural lines, and small consolidation. Normal CXR was found in 17.89% of cases. The study found LUS to be non-inferior to CXR for diagnostic accuracy and COVID-positive patients were most likely to show B lines and sub-pleural consolidations on LUS examination.

Mammography System (Analog)
MAM VENUS
Biopsy Software
Affirm® Contrast
Breast Localization System
MAMMOREP LOOP
Ultrasound Needle Guidance System
SonoSite L25

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.